NL-OMON49821尚未招募不适用
Validation and implementation of rapid testing for SARS-CoV-2 in the primary care setting - COVID-19 rapid test in urgent primary care
HADOKS0 个研究点目标入组 1,500 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients 18 years and older who visit the corona urgent primary care
- •facility of the HADOKS (location Haga, Leyweg, The Hague) or the SHR/DDDB
- •(location Alrijne, Leiderdorp).
排除标准
- •Children younger than 18 years of age.
- •Insufficient understanding of the Dutch language.
- •Recent (< 12 hours) intake of alcohol.
- •Administration of remdesivir and/or dexamethasone before study procedures.
研究者
相似试验
尚未招募
不适用
Evaluantion of a new rapid diagnostic test to indetify patients with resistance for tuberculosis´ drugs in BrazilTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantSpecial screening examination for respiratory tuberculosisA00-B99TuberculosisRBR-3jpsv2Programa Nacional de Controle da Tuberculose CGPNCT / DEVIT Secretaria de Vigilância em Saúde/Ministério da Saúde
尚未招募
不适用
Evaluation study of a rapid test and treatments for Chagas disease in Bahia, BrazilMass ScreeningDrug therapyC01.920.625RBR-5zfkxdyCentro de Pesquisas Gonçalo Moniz
尚未招募
2 期
Development of standard procedure of Uttara Basti including its validation and reliability testing.CTRI/2023/05/053137ATIONAL INSTITUTE OF AYURVEDA
尚未招募
不适用
A performance evaluation study for the testing of DNA extracted from either tumor tissue biopsy samples or plasma, using the therascreen® EGFR Plus RGQ PCR Kit, from subjects with Non-Small Cell Lung Cancer, being screened for inclusion in Taiho Oncology, Inc*s Clinical Trial (Protocol No. 10073010).Non Small Cell Lung Cancer10038666Lung CancerNL-OMON56744QIAGE15
已完成
不适用
Reliability and Validity of a new test method to measure the ability for physical relaxatioWe examine both healthy people and people with underlying health conditions.DRKS00030777ni-Zentrum Naturheilkunde Freiburg94